|
Market Closed -
Nasdaq Stockholm
20:30:00 30/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 16.22 SEK | -3.22% |
|
-5.92% | -28.23% |
| 10-27 | Synact Pharma enters commercial agreement with Brazilian company Hipolabor | FW |
| 10-27 | SynAct Pharma enters partnership agreement for resomelagon with Brazilian pharmaceutical company | FW |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SYNACT PHARMA AB | Other Pharmaceuticals | -3.22% | -5.92% | -28.23% | -32.98% | -86.64% | 92.46M |  |  |  |
- Stock Market
- Stocks
- SYNACT Stock
- Charts SynAct Pharma AB
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
